Skip to content
ppharmaranks
Menu
Class IIOngoing

TESTOSTERONE PELLET 200 mg BLUNT recall

FDA recall D-0416-2025 · initiated Apr 28, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 14, 2025How we research

BSO LLC recalled TESTOSTERONE PELLET 200 mg BLUNT in Apr 2025 — an FDA Class II recall (D-0416-2025) because Presence of Particulate Matter: Glass particles were found in pellet vials.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Particulate Matter: Glass particles were found in pellet vials.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot 20250129@1, exp 1/17/2026; Lot 20250218@4, exp 1/25/2026

Quantity recalled: 1,964 vials

Details

Product
TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01
Recalling company
BSO LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Apr 28, 2025
FDA report date
May 14, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was TESTOSTERONE PELLET 200 mg BLUNT recalled?
BSO LLC recalled TESTOSTERONE PELLET 200 mg BLUNT in Apr 2025 — an FDA Class II recall (D-0416-2025) because Presence of Particulate Matter: Glass particles were found in pellet vials. May cause temporary or medically reversible harm; low probability of serious harm.
Why was TESTOSTERONE PELLET 200 mg BLUNT recalled?
Per the FDA enforcement record, the reason for recall D-0416-2025 was: Presence of Particulate Matter: Glass particles were found in pellet vials.
Is a recalled TESTOSTERONE PELLET 200 mg BLUNT dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of TESTOSTERONE PELLET 200 mg BLUNT are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot 20250129@1, exp 1/17/2026; Lot 20250218@4, exp 1/25/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0416-2025.

Source: openFDA Drug Enforcement record D-0416-2025

← All drug recalls